Jul 25 |
Novocure Reports Second Quarter 2024 Financial Results
|
Jul 24 |
NovoCure Q2 2024 Earnings Preview
|
Jul 1 |
Novocure to Report Second Quarter 2024 Financial Results
|
Jun 4 |
A Closer Look at 7 Analyst Recommendations For NovoCure
|
Jun 3 |
NovoCure Tumor Treating Fields decreases progression of brain metastases
|
Jun 3 |
METIS Phase 3 Clinical Trial Met Primary Endpoint Significantly Delaying Time to Intracranial Progression with Improved Quality of Life Deterioration-Free Survival
|
May 23 |
TIGER Study Reports New TTFields Therapy Survival Results for Newly Diagnosed Glioblastoma Patients in Germany
|
May 14 |
Double-Up Delights: 7 Stocks Poised to Soar 100% by 2025
|
May 3 |
NovoCure Limited Q1 Earnings: Core Business Accelerating
|
May 3 |
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
|